12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cialis regulatory update

EMA's CHMP issued a positive opinion to expand the indication for 5 mg Cialis tadalafil from Eli Lilly to include the treatment of signs and symptoms of benign prostatic hyperplasia (BPH) in adult males, including...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >